Magno Maciel-Magalhães
Magno Maciel-Magalhães has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Beatriz Ferreira de Carvalho Patricio
Universidade Federal do Estado do Rio de Janeiro (UNIRIO)
3 shared publications - Fabio Coelho Amendoeira
Laboratório de Farmacologia, Instituto Nacional de Controle de Qualidade em Saúde Fundação Oswaldo Cruz Rio de Janeiro Brazil
3 shared publications - Beatriz Rodrigues Canabarro
Centro Brasileiro de Pesquisas Físicas (CBPF)
2 shared publications - Fausto Klabund Ferraris
Laboratório de Farmacologia, Instituto Nacional de Controle de Qualidade em Saúde Fundação Oswaldo Cruz Rio de Janeiro Brazil
2 shared publications - Renata Jurema Medeiros
Instituto Nacional de Controle de Qualidade Em Saúde, Fundação Oswaldo Cruz, Av. Brasil, 4365, Manguinhos, Rio de Janeiro 21040‑900, Brazil
2 shared publications - Ayelen Morena Sosa
Departamento de Ciencia y Tecnología, Laboratorio de Bio‐Nanotecnología (LBN) Universidad Nacional de Quilmes Buenos Aires Argentina
1 shared publication
Latest Publications
- Open Access
- 22 September 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (39) , 60104-60118
A Comparative Analysis of Zinc Oxide as Nanoparticles and Its Bulk Form through In Vitro Toxicogenetics and In Vivo Zebrafish Embryotoxicity Models
Zinc oxide nanoparticles (ZnO-NP) are widely used due to their enhanced biological activity compared to the bulk counterpart (ZnO-BK), raising concerns about potential toxic effects on living organisms and the environment. This study investigated the toxicity of ZnO-NP and ZnO-BK using alternative in vitro and in vivo models. The Salmonella/Microsome assay (±metabolic activation) was conducted according to the Organisation for Economic Co-operation and Development (OECD) guidelines. HepG2 cell viability and genotoxicity were assessed using the WST-1 and cytokinesis-block micronucleus (CBMN) assays. Acute toxicity was evaluated using the fish embryotoxicity (FET) test in zebrafish (Danio rerio) embryos. Both forms induced mutagenic responses in TA98 and TA102 strains, while ZnO-BK showed mutagenicity in TA100 only in the absence of metabolic activation. In HepG2 cells, both forms induced dose-dependent cytotoxicity in the WST-1 model, with ZnO-BK exhibiting greater cytotoxic potency. The CBMN assay revealed higher cytogenetic damage for ZnO-BK, including micronuclei, nuclear buds, and nucleoplasmic bridges, while both forms exhibited dose-dependent cytotoxic and cytostatic effects. In vivo, ZnO-NP exerted a more pronounced impact on embryonic development, altering eye diameter and body size compared to ZnO-BK. Overall, both forms demonstrated significant toxicological effects, highlighting their relevance for regulatory toxicogenetics and environmental safety.
- 22 September 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (39) , 60104-60118
Open AccessA Comparative Analysis of Zinc Oxide as Nanoparticles and Its Bulk Form through In Vitro Toxicogenetics and In Vivo Zebrafish Embryotoxicity Models
Zinc oxide nanoparticles (ZnO-NP) are widely used due to their enhanced biological activity compared to the bulk counterpart (ZnO-BK), raising concerns about potential toxic effects on living organisms and the environment. This study investigated the toxicity of ZnO-NP and ZnO-BK using alternative in vitro and in vivo models. The Salmonella/Microsome assay (±metabolic activation) was conducted according to the Organisation for Economic Co-operation and Development (OECD) guidelines. HepG2 cell viability and genotoxicity were assessed using the WST-1 and cytokinesis-block micronucleus (CBMN) assays. Acute toxicity was evaluated using the fish embryotoxicity (FET) test in zebrafish (Danio rerio) embryos. Both forms induced mutagenic responses in TA98 and TA102 strains, while ZnO-BK showed mutagenicity in TA100 only in the absence of metabolic activation. In HepG2 cells, both forms induced dose-dependent cytotoxicity in the WST-1 model, with ZnO-BK exhibiting greater cytotoxic potency. The CBMN assay revealed higher cytogenetic damage for ZnO-BK, including micronuclei, nuclear buds, and nucleoplasmic bridges, while both forms exhibited dose-dependent cytotoxic and cytostatic effects. In vivo, ZnO-NP exerted a more pronounced impact on embryonic development, altering eye diameter and body size compared to ZnO-BK. Overall, both forms demonstrated significant toxicological effects, highlighting their relevance for regulatory toxicogenetics and environmental safety.
- Open Access
- 21 September 2026
- Published by Elsevier in Aquatic Toxicology
- Vol. 301
Cocaine and benzoylecgonine in urban rivers: Occurrence, developmental toxicity and oxidative stress in zebrafish embryos
- 21 September 2026
- Published by Elsevier in Aquatic Toxicology
- Vol. 301
Open AccessCocaine and benzoylecgonine in urban rivers: Occurrence, developmental toxicity and oxidative stress in zebrafish embryos
- Open Access
- 10 November 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (46) , 55392-55403
Enhanced Skin Delivery of Amphotericin B: Development and Evaluation of Polymeric Nanoparticles Using a Porcine Ear Model
Amphotericin B (AmB) is a widely used antifungal drug that is also prescribed to some neglected diseases, such as leishmaniasis. Its usage is limited by its low oral bioavailability and side effects, leading to the exploration of alternative delivery systems. Polymeric nanoparticles (PNPs) have emerged as a promising drug delivery pathway, offering potential benefits such as controlled release and improved drug bioavailability. In this work, AmB-loaded poly(lactic acid) (PLA) and polycaprolactone (PCL) PNPs were produced by nanoprecipitation and characterized by dynamic light scattering, scanning transmission electron microscopy, and Raman spectroscopy. Subsequently, their stability was tested in static multiple light scattering (SMLS) analysis, and their penetrability was determined in an ex vivo porcine skin model. The obtained results indicated that the PNPs were successfully produced. The PLA + AmB PNPs were able to reach the viable epidermis, while the PCL + AmB PNPs permeated the stratum corneum, suggesting that both may be useful for the topical treatment of fungal infections and cutaneous leishmaniasis.
- 10 November 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (46) , 55392-55403
Open AccessEnhanced Skin Delivery of Amphotericin B: Development and Evaluation of Polymeric Nanoparticles Using a Porcine Ear Model
Amphotericin B (AmB) is a widely used antifungal drug that is also prescribed to some neglected diseases, such as leishmaniasis. Its usage is limited by its low oral bioavailability and side effects, leading to the exploration of alternative delivery systems. Polymeric nanoparticles (PNPs) have emerged as a promising drug delivery pathway, offering potential benefits such as controlled release and improved drug bioavailability. In this work, AmB-loaded poly(lactic acid) (PLA) and polycaprolactone (PCL) PNPs were produced by nanoprecipitation and characterized by dynamic light scattering, scanning transmission electron microscopy, and Raman spectroscopy. Subsequently, their stability was tested in static multiple light scattering (SMLS) analysis, and their penetrability was determined in an ex vivo porcine skin model. The obtained results indicated that the PNPs were successfully produced. The PLA + AmB PNPs were able to reach the viable epidermis, while the PCL + AmB PNPs permeated the stratum corneum, suggesting that both may be useful for the topical treatment of fungal infections and cutaneous leishmaniasis.
- Open Access
- 16 January 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (1) , 116
Amphotericin B Encapsulation in Polymeric Nanoparticles: Toxicity Insights via Cells and Zebrafish Embryo Testing
Background: Amphotericin B (AmB) is a commonly utilized antifungal agent, which is also recommended for the treatment of certain neglected tropical diseases, including leishmaniasis. However, its clinical application is constrained because of its poor oral bioavailability and adverse effects, prompting the investigation of alternative drug delivery systems. Polymeric nanoparticles (PNPs) have gained attention as a potential drug delivery vehicle, providing advantages such as sustained release and enhanced bioavailability, and could have potential as AmB carriers. However, concerns persist regarding nanomaterials’ toxicity, requiring more studies. Zebrafish (Danio rerio) embryos were used as a valuable model for toxicity testing, especially because of their genetic similarity to humans and standardized developmental assessments. Methods: In this study, we produced and characterized AmB loaded and non-loaded PNPs by nanoprecipitation, dynamic light scattering, transmission electron microscopy, atomic force microscopy and spectroscopy. Afterwards, we verified their toxicity through in vitro MTT assays in three cell lines (HEK293, HepG2, and J774 A1) and in vivo tests with zebrafish embryos. Results: In both trials, it was noted that nanoencapsulation of the drug led to increased toxicity when compared to non-encapsulated AmB, possibly indicating that they penetrated the embryo’s chorion. Nevertheless, it was demonstrated that the polymers used are safe and they are not the cause of toxicity, neither are the nanostructures per se. Conclusions: Therefore, it is believed that the objective of improving the bioavailability of AmB may have been achieved, and the observed toxicity was probably linked to AmB’s ability to destabilize cell membranes.
- 16 January 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (1) , 116
Open AccessAmphotericin B Encapsulation in Polymeric Nanoparticles: Toxicity Insights via Cells and Zebrafish Embryo Testing
Background: Amphotericin B (AmB) is a commonly utilized antifungal agent, which is also recommended for the treatment of certain neglected tropical diseases, including leishmaniasis. However, its clinical application is constrained because of its poor oral bioavailability and adverse effects, prompting the investigation of alternative drug delivery systems. Polymeric nanoparticles (PNPs) have gained attention as a potential drug delivery vehicle, providing advantages such as sustained release and enhanced bioavailability, and could have potential as AmB carriers. However, concerns persist regarding nanomaterials’ toxicity, requiring more studies. Zebrafish (Danio rerio) embryos were used as a valuable model for toxicity testing, especially because of their genetic similarity to humans and standardized developmental assessments. Methods: In this study, we produced and characterized AmB loaded and non-loaded PNPs by nanoprecipitation, dynamic light scattering, transmission electron microscopy, atomic force microscopy and spectroscopy. Afterwards, we verified their toxicity through in vitro MTT assays in three cell lines (HEK293, HepG2, and J774 A1) and in vivo tests with zebrafish embryos. Results: In both trials, it was noted that nanoencapsulation of the drug led to increased toxicity when compared to non-encapsulated AmB, possibly indicating that they penetrated the embryo’s chorion. Nevertheless, it was demonstrated that the polymers used are safe and they are not the cause of toxicity, neither are the nanostructures per se. Conclusions: Therefore, it is believed that the objective of improving the bioavailability of AmB may have been achieved, and the observed toxicity was probably linked to AmB’s ability to destabilize cell membranes.
- Open Access
- 26 February 2021
- Published by Vigilancia Sanitaria em Debate: Sociedade, Ciencia y Tecnologia in Vigilância Sanitária Em Debate: Sociedade, Ciência & Tecnologia
- Vol. 9 (1) , 117-122
Importância da inserção de grupo controle em ensaios utilizando animais de laboratório
Introdução: O uso de animais de laboratório é fundamental em áreas em que ainda não podem ser substituídos na totalidade, como a toxicologia. Em estudos que se utilizam, para fins de comparação, apenas dados fornecidos pelos laboratórios de análises clínicas, na tentativa de reduzir o número de animais de um experimento, arrisca-se utilizar informações que não correspondem à realidade. Objetivo: Debater o uso de grupo controle em experimentos com animais. Método: Este artigo comparou valores hematológicos e bioquímicos de ratos da linhagem Wistar, obtidos em três biotérios de criação de diferentes estados brasileiros, com os resultados de animais provindos do Instituto de Ciência e Tecnologia em Biomodelos da Fundação Oswaldo Cruz, Rio de Janeiro, objetivando a discussão acerca da tomada de decisão sobre a inclusão de grupo controle em ensaios de toxicidade aguda oral. Resultados: Poucos foram os parâmetros que não apresentaram diferenças estatísticas, tais como: hemácia em fêmeas (duas referências), hemoglobina em fêmeas (uma referência) e machos (uma referência), hematócrito nos machos (duas referências) e hemoglobina corpuscular média nas fêmeas (duas referências), leucócitos nos machos (uma referência), creatinina e alanina aminotransferase (ALT) em todas as fêmeas. Conclusões: O uso do grupo controle se faz necessário quando valores analisados preliminarmente apresentam-se discrepantes daqueles tidos como referenciais da espécie.
- 26 February 2021
- Published by Vigilancia Sanitaria em Debate: Sociedade, Ciencia y Tecnologia in Vigilância Sanitária Em Debate: Sociedade, Ciência & Tecnologia
- Vol. 9 (1) , 117-122
Open AccessImportância da inserção de grupo controle em ensaios utilizando animais de laboratório
Introdução: O uso de animais de laboratório é fundamental em áreas em que ainda não podem ser substituídos na totalidade, como a toxicologia. Em estudos que se utilizam, para fins de comparação, apenas dados fornecidos pelos laboratórios de análises clínicas, na tentativa de reduzir o número de animais de um experimento, arrisca-se utilizar informações que não correspondem à realidade. Objetivo: Debater o uso de grupo controle em experimentos com animais. Método: Este artigo comparou valores hematológicos e bioquímicos de ratos da linhagem Wistar, obtidos em três biotérios de criação de diferentes estados brasileiros, com os resultados de animais provindos do Instituto de Ciência e Tecnologia em Biomodelos da Fundação Oswaldo Cruz, Rio de Janeiro, objetivando a discussão acerca da tomada de decisão sobre a inclusão de grupo controle em ensaios de toxicidade aguda oral. Resultados: Poucos foram os parâmetros que não apresentaram diferenças estatísticas, tais como: hemácia em fêmeas (duas referências), hemoglobina em fêmeas (uma referência) e machos (uma referência), hematócrito nos machos (duas referências) e hemoglobina corpuscular média nas fêmeas (duas referências), leucócitos nos machos (uma referência), creatinina e alanina aminotransferase (ALT) em todas as fêmeas. Conclusões: O uso do grupo controle se faz necessário quando valores analisados preliminarmente apresentam-se discrepantes daqueles tidos como referenciais da espécie.